JEFF KNIGHT plan to sell securities of Crinetics Pharmaceuticals, Inc. under Form 144

JEFF KNIGHT filed Form 144 to notify SEC of plan to sell 4434 units of Crinetics Pharmaceuticals, Inc. securities around 2026-04-13, with aggregate market value of $174,876.96. The total outstanding units is 104705330.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On 04/08/2026, sold 85163 units for $3414701.10; On 03/16/2026, sold 9911 units for $370411.47;